Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin

<p>Abstract</p> <p>Background</p> <p>No data regarding metformin effects on follicular fluid anti-Müllerian hormone (AMH) levels were to date available in literature. The aim of the present study was to evaluate in patients with polycystic ovary syndrome (PCOS) whether...

Full description

Bibliographic Details
Main Authors: Falbo Angela, Rocca Morena, Russo Tiziana, D'Ettore Antonietta, Tolino Achille, Zullo Fulvio, Orio Francesco, Palomba Stefano
Format: Article
Language:English
Published: BMC 2010-07-01
Series:Journal of Ovarian Research
Online Access:http://www.ovarianresearch.com/content/3/1/16
_version_ 1797971049345712128
author Falbo Angela
Rocca Morena
Russo Tiziana
D'Ettore Antonietta
Tolino Achille
Zullo Fulvio
Orio Francesco
Palomba Stefano
author_facet Falbo Angela
Rocca Morena
Russo Tiziana
D'Ettore Antonietta
Tolino Achille
Zullo Fulvio
Orio Francesco
Palomba Stefano
author_sort Falbo Angela
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>No data regarding metformin effects on follicular fluid anti-Müllerian hormone (AMH) levels were to date available in literature. The aim of the present study was to evaluate in patients with polycystic ovary syndrome (PCOS) whether metformin administration affects serum and follicular AMH levels, and whether this is related to ovarian response to the treatment.</p> <p>Methods</p> <p>Twenty young patients with PCOS who had received metformin were enrolled. Ten patients were anovulatory (Met-anov group), whereas the other 10 were ovulatory (Met-ov group) but had failed to conceive. Further untreated PCOS (PCOS controls, n. 10) and healthy controls (non-PCOS controls, n. 10) who were scheduled for laparoscopic surgery were enrolled. In each subjects, clinical and biochemical evaluations were performed. AMH concentrations in blood and antral follicular fluid were assayed.</p> <p>Results</p> <p>In both Met-anov and Met-ov groups, and without difference between them, serum androgens and AMH, and indices of insulin resistance were significantly (<it>p </it>< 0.05) improved after treatment. On the other hand, significant differences (<it>p </it>< 0.05) between the two groups were detected with respect to the same biochemical parameters in antral follicular fluid. In the Met-anov group, no significant correlation was observed between AMH concentrations in the follicular fluid and variation in serum androgens, AMH and insulin resistance indexes; whereas in Met-ov group significant correlations were detected between AMH levels in the follicular fluid and variation in serum androgens, AMH and insulin resistance indexes.</p> <p>Conclusions</p> <p>Metformin administration in patients with PCOS exerts a differential action on the ovarian AMH levels on the basis of ovulatory response. Changes in AMH levels in antral follicular fluid during metformin treatment could be involved in the local mechanisms mediating the ovulatory restoration.</p>
first_indexed 2024-04-11T03:26:34Z
format Article
id doaj.art-1b7fcba87ff94243b667cf7e585e13a7
institution Directory Open Access Journal
issn 1757-2215
language English
last_indexed 2024-04-11T03:26:34Z
publishDate 2010-07-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj.art-1b7fcba87ff94243b667cf7e585e13a72023-01-02T07:13:36ZengBMCJournal of Ovarian Research1757-22152010-07-01311610.1186/1757-2215-3-16Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metforminFalbo AngelaRocca MorenaRusso TizianaD'Ettore AntoniettaTolino AchilleZullo FulvioOrio FrancescoPalomba Stefano<p>Abstract</p> <p>Background</p> <p>No data regarding metformin effects on follicular fluid anti-Müllerian hormone (AMH) levels were to date available in literature. The aim of the present study was to evaluate in patients with polycystic ovary syndrome (PCOS) whether metformin administration affects serum and follicular AMH levels, and whether this is related to ovarian response to the treatment.</p> <p>Methods</p> <p>Twenty young patients with PCOS who had received metformin were enrolled. Ten patients were anovulatory (Met-anov group), whereas the other 10 were ovulatory (Met-ov group) but had failed to conceive. Further untreated PCOS (PCOS controls, n. 10) and healthy controls (non-PCOS controls, n. 10) who were scheduled for laparoscopic surgery were enrolled. In each subjects, clinical and biochemical evaluations were performed. AMH concentrations in blood and antral follicular fluid were assayed.</p> <p>Results</p> <p>In both Met-anov and Met-ov groups, and without difference between them, serum androgens and AMH, and indices of insulin resistance were significantly (<it>p </it>< 0.05) improved after treatment. On the other hand, significant differences (<it>p </it>< 0.05) between the two groups were detected with respect to the same biochemical parameters in antral follicular fluid. In the Met-anov group, no significant correlation was observed between AMH concentrations in the follicular fluid and variation in serum androgens, AMH and insulin resistance indexes; whereas in Met-ov group significant correlations were detected between AMH levels in the follicular fluid and variation in serum androgens, AMH and insulin resistance indexes.</p> <p>Conclusions</p> <p>Metformin administration in patients with PCOS exerts a differential action on the ovarian AMH levels on the basis of ovulatory response. Changes in AMH levels in antral follicular fluid during metformin treatment could be involved in the local mechanisms mediating the ovulatory restoration.</p>http://www.ovarianresearch.com/content/3/1/16
spellingShingle Falbo Angela
Rocca Morena
Russo Tiziana
D'Ettore Antonietta
Tolino Achille
Zullo Fulvio
Orio Francesco
Palomba Stefano
Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
Journal of Ovarian Research
title Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
title_full Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
title_fullStr Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
title_full_unstemmed Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
title_short Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
title_sort serum and follicular anti mullerian hormone levels in women with polycystic ovary syndrome pcos under metformin
url http://www.ovarianresearch.com/content/3/1/16
work_keys_str_mv AT falboangela serumandfollicularantimullerianhormonelevelsinwomenwithpolycysticovarysyndromepcosundermetformin
AT roccamorena serumandfollicularantimullerianhormonelevelsinwomenwithpolycysticovarysyndromepcosundermetformin
AT russotiziana serumandfollicularantimullerianhormonelevelsinwomenwithpolycysticovarysyndromepcosundermetformin
AT dettoreantonietta serumandfollicularantimullerianhormonelevelsinwomenwithpolycysticovarysyndromepcosundermetformin
AT tolinoachille serumandfollicularantimullerianhormonelevelsinwomenwithpolycysticovarysyndromepcosundermetformin
AT zullofulvio serumandfollicularantimullerianhormonelevelsinwomenwithpolycysticovarysyndromepcosundermetformin
AT oriofrancesco serumandfollicularantimullerianhormonelevelsinwomenwithpolycysticovarysyndromepcosundermetformin
AT palombastefano serumandfollicularantimullerianhormonelevelsinwomenwithpolycysticovarysyndromepcosundermetformin